Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

344.793
-6.744-1.92%
Number of Gainers:31
Number of Losers:20
Number of Flat:8
PE:- -
High:351.624
Open:351.535
Low:340.025
Close:351.537
Volume:127.71M
Turnover:4.85B
Market Cap:827.49B
Float Cap:711.95B

Loading ...

CH GENERAL EDU (02175) Provides Update on Acquisition Consideration Adjustment Talks

Deep News
·
Aug 23

ZYLOXTB Completes Share Buyback Worth Approximately HK$72,200

Stock News
·
Aug 23

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Repurchase for Treasury Shares

Reuters
·
Aug 23

China General Education Seeks Price Cut in Target Acquisition as Profit Goal Looks Out of Reach

Reuters
·
Aug 23

Wei Dongyi Removes Math Workbooks from Online Store After Selling Over 1 Million Yuan in Four Days

Deep News
·
Aug 23

Citi Raises Keymed Bio Target Price to HK$97.5, Keeps Buy/High Risk Call

Deep News
·
Aug 23

Daiwa Raises KEYMED BIO-B Price Target to HK$110, Reaffirming Buy Call

Deep News
·
Aug 23

Keymed Biosciences Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Simply Wall St.
·
Aug 22

Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook

Reuters
·
Aug 22

Betterlife Holding Expects HY Loss of up to RMB 105 Million

Reuters
·
Aug 21

Massive Recall of Over 4 Million Vehicles Addresses Door Handle Safety Flaw That Could Hinder Emergency Escape

Deep News
·
Aug 21

Linklogis (SEHK:9959) Stock Rebounds As Profit Returns But Valuation Stays Rich

Simply Wall St.
·
Aug 21

China General Education Group Files Board, Committee Member List with Disclosure Responsibilities

Reuters
·
Aug 21

BetterLife Expects H1 Loss Attributable to Owners up to RMB 105 Million

Reuters
·
Aug 21

BetterLife Holding - Expects Loss of up to Rmb105 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 21

BetterLife Holding - Expected Hy Profit Decrease Mainly Due to Lower Automobile Sales and Weak Market Sentiment

THOMSON REUTERS
·
Aug 21

Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals

Reuters
·
Aug 21

China's Jinxin Fertility Group Interim Revenue Rises on U.S. IVF Demand

Reuters
·
Aug 21

Citi Raises Keymed Bio's Target Price to HK$97.5, Maintains Buy/High-Risk Rating

Stock News
·
Aug 21

Norway's Medistim Q2 Revenue Rises on Own-Product Sales Growth

Reuters
·
Aug 21